News & Perspective

Jun 07, 2012

Jun 07, 2012

Drug-resistant TB studies show burden in China, new antibiotic results

(CIDRAP News) – Two groups of tuberculosis (TB) researchers released new findings today, giving the world its first look at drug-resistant TB at the national level in China and presenting encouraging findings for the new antibiotic delamanid for the multidrug-resistant (MDR) form of the disease.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»